Weili Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Weili Yang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fengguang Zhai
Zhejiang Key Laboratory of Pathophysiology, Department of Biochemistry and Molecular Biology, Health Science Center of Ningbo University, Ningbo 315211, China
1 shared publication - Jie Wang
The First Affiliated Hospital of Ningbo University
1 shared publication Linglin Sun
Department of Radiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, No. 261, Huansha Road, Hangzhou 310006 China
1 shared publication- Meng Ye
Department of Biochemistry and Molecular Biology, Health Science Center, Ningbo University, Ningbo, China
1 shared publication - Qiang Li
Huazhong University of Science and Technology
1 shared publication - Tao Ye
Department of Radiology, The Affiliated People' S Hospital of Ningbo University, Ningbo 315040, China
1 shared publication
Latest Publications
- 19 January 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 183, 111940
Radiological evaluation of pelvic venous Disorders: A comprehensive review
- 19 January 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 183, 111940
Radiological evaluation of pelvic venous Disorders: A comprehensive review
- Open Access
The E3 Ligases in Cervical Cancer and Endometrial Cancer
Endometrial (EC) and cervical (CC) cancers are the most prevalent malignancies of the female reproductive system. There is a global trend towards increasing incidence and mortality, with a decreasing age trend. E3 ligases label substrates with ubiquitin to regulate their activity and stability and are involved in various cellular functions. Studies have confirmed abnormal expression or mutations of E3 ligases in EC and CC, indicating their vital roles in the occurrence and progression of EC and CC. This paper provides an overview of the E3 ligases implicated in EC and CC and discusses their underlying mechanism. In addition, this review provides research advances in the target of ubiquitination processes in EC and CC.
Open AccessThe E3 Ligases in Cervical Cancer and Endometrial Cancer
Endometrial (EC) and cervical (CC) cancers are the most prevalent malignancies of the female reproductive system. There is a global trend towards increasing incidence and mortality, with a decreasing age trend. E3 ligases label substrates with ubiquitin to regulate their activity and stability and are involved in various cellular functions. Studies have confirmed abnormal expression or mutations of E3 ligases in EC and CC, indicating their vital roles in the occurrence and progression of EC and CC. This paper provides an overview of the E3 ligases implicated in EC and CC and discusses their underlying mechanism. In addition, this review provides research advances in the target of ubiquitination processes in EC and CC.